Specialty Pharmacy

High-intensity interval training found to increase ’ maximum oxygen uptake and improve the heart recovery rate in RA patients.

ACOs combined for a total net savings of $411 million in 2014.

Aggressive surgery to remove all cancer cells followed by targeted chemotherapy shows potential to significantly improve ovarian cancer survival.

Top news of the week in cancer drug development and research.

Estrogen found to reduce the ability of the immune system to attack the brain in MS patients.

Catch up with the latest developments across the health care landscape and sign up for key upcoming conferences.

Venetoclax is a B-cell lymphoma-2 protein inhibitor for the treatment of CLL patients who received a least one prior therapy.

Researchers explore digital health solutions for COPD symptom management.

Tumors that over-express a specific oncogene may benefit from combination therapy regardless of cancer type.

New research may transform oncology drug development.

Researchers warn political interference may discourage shared decision-making in breast cancer treatment.

Use of exomes shield lung cancer drug from immune system defenses.

Top stories of the week on Specialty Pharmacy Times.

Patients with inflammatory rheumatic diseases may not need more frequent vaccinations.

Traditional cancer therapies like chemotherapy or radiation are not generally effective for colorectal cancer patients.

HCV treatment has been shown to cure up to 100% of patients depending on genotype and stage of liver disease.

Being overweight or obese associated with a decreased risk of subsequent RA diagnosis.

Acceptance is a multiple sclerosis treatment goal because it is associated with better drug adherence.

Carfilzomib approved in combination with dexamethasone, or with lenalidomide plus dexamethasone, for patients with relapsed/refractory multiple myeloma.

A young Navy veteran finds hope in his struggle with amyotrophic lateral sclerosis, as the hunt for a cure continues.

David Lassen, chief clinical officer at Prime Therapeutics, discusses important developments in specialty pharmacy.

AJPB.com provides daily news and insights on formulary management strategies.

Researchers examine use of docetaxel in patients with castration-resistant metastatic prostate cancer following androgen-deprivation therapy.

Byproduct found in cotton plant rid the body of abnormal cancerous cells.

Study finds presence of additional environmental risk factors affect the etiology of multiple sclerosis.

HIV prevention and treatment recommendations for adults can be found with new AIDSinfo app.

Abbott's Compounding Pharmacy is voluntarily recalling all of its unexpired lots of sterile compounded products, including injectable medications, eye drops, sterile solutions, and eye ointments, out of concern for sterility assurance.

One-third of HIV-infected Americans are co-infected with hepatitis C virus (HCV), and 75% to 90% of HIV-positive intravenous drug users are co-infected.

A pharmacist facing sentencing in March for defrauding Medicaid has been found dead in his house.

Researchers examine how genetic changes in breast cancer cells interfere with pathways critical to disease growth and survival.